Skip to main content
Premium Trial:

Request an Annual Quote

Oxford Gene Technology

Oxford Gene Technology has extended its Chip2 family of ChIP-on-chip microarray products with the addition of four prokaryote species. These include Escherichia coli 0157, Salmonella typhimurium LT2, S. typhimurium SL1344, and Streptomyces coelicolor.  
The Chip2 microarrays can be used to identify the binding positions of global DNA-binding proteins, analyze changes in a particular protein’s binding under “various environmental conditions,” or to reveal potential therapeutic targets against a prokaryotic species.   
Each Chip2 microarray is fabricated using OGT’s ink-jet in situ synthesis platform and interrogates the genome of interest with a probe density of 22,000 oligonucleotide features.

ChIP microarray data generated can then be analyzed in relation to its relative gene position using an OGT-developed ChIP browser.

Filed under

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.